Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v12-FR
Language French French
Date Updated 2021-11-11 2021-11-10
Drug Identification Number 02223406 02223406
Brand name INTRON A INTRON A
Common or Proper name interferon alfa-2b lyophilized powder interferon alfa-2b lyophilized powder
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients WATER INTERFERON ALFA-2B WATER INTERFERON ALFA-2B
Strength(s) 1ML 10000000UNIT 1ML 10000000UNIT
Dosage form(s) LIQUID POWDER FOR SOLUTION LIQUID POWDER FOR SOLUTION
Route of administration INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1 x 10MIU 1 x 10MIU
ATC code L03AB L03AB
ATC description IMMUNOSTIMULANTS IMMUNOSTIMULANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2021-11-12 2021-11-12
Actual discontinuation date 2021-11-10 2021-11-10
Remaining supply date 2021-11-12 2021-11-12
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments